Clinical Features of COVID-19 Patients

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 13, 2020

Primary Completion Date

October 28, 2023

Study Completion Date

November 13, 2023

Conditions
Covid19Acute Respiratory Distress SyndromeVentilatory Failure
Interventions
DIAGNOSTIC_TEST

peripheral lymphocytes subsets

The data were collected during the first and the second wave of epidemic in COVID-19 patients with acute respiratory distress syndrome. At the moment of hospitalization, at the moment of intensive care unit admission and during the in intensive care unit staying, the following data were collected: peripheral lymphocyte subsets were measured by multiple-color flow cytometry, chest computed tomography and ultrasonography scans (lung ultrasound score, diaphragmatic thickness and motion), arterial blood gas analysis parameters (pH, partial pressure of carbon dioxide, partial pressure of oxygen, concentration of hydrogen carbonate, base excess, and arterial oxygen saturation ), and pain assessed by using numeric rating scale. Macroscopic and microscopic hypopharynx and larynx damages were also evaluated by video-laryngoscopy and light miscoscopy.

Trial Locations (1)

67100

San Salvatore Academic Hospital, L’Aquila

All Listed Sponsors
lead

San Salvatore Hospital of L'Aquila

OTHER

NCT04815304 - Clinical Features of COVID-19 Patients | Biotech Hunter | Biotech Hunter